Clinical Trial Update: Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) [Phase 1, Phase 2]

View source ↗

Summary

Long-term follow-up results for everolimus (RAD001) therapy in patients with tuberous sclerosis complex-associated angiomyolipoma and sporadic lymphangioleiomyo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiomyolipoma
• Lymphangioleiomyomatosis
• Tuberous Sclerosis Complex

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Tuberous Sclerosis, Angiolipoma | Phase 1, Phase 2 | Status: COMPLETED